68 results
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
; claims of wrongful discharge, constructive discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract, and breach
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
discharge, constructive discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract, and breach of the covenant of good faith
8-K
EX-10.1
KA
Kineta Inc
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data
8-K
EX-10.1
KA
Kineta Inc
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
8-K
EX-10.6
8z9jmtujqralcd
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.6
z70vscwlrg7n7nmm
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
7zv j6xi6yae1
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.16
8b4u9rfyv47g ejh
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.17
e0f6tnyw
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.15
y7on3
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
88gu20r7kodl88ab
10 Nov 22
Prospectus supplement
4:21pm